Syngene International Limited has informed the Exchange regarding a press release dated January 19, 2026, titled "Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035".
Press Release Jan 19 2026
Earlier from Syngene International
- Press Release Nov 05 2025
- Syngene International announces plans to add bioconjugation suite for end-to-end Antibody-Drug Conjugates Development